EFFICACY OF BECOMETASONE DIPROPIONATE ON MICROSCOPIC COLITIS

• Conditions: Microscopic colitis; MedDRA version: 14.1Level: PTClassification code 10056979Term: Colitis microscopicSystem Organ Class: 10017947 - Gastrointestinal disorders; MedDRA version: 14.1Level: LLTClassification code 10048928Term: Colitis collagenousSystem Organ Class: 10017947 - Gastrointestinal disorders; MedDRA version: 14.1Level: LLTClassification code 10025268Term: Lymphocytic colitisSystem Organ Class: 10017947 - Gastrointestinal disorders; Therapeutic area: Diseases [C] - Digestive System Diseases [C06]

• Registration Number: EUCTR2009-017240-14-ES
• Lead Sponsor: ASOCIACIÓN GALLEGA DE ENFERMEDAD INFLAMATORIA INTESTITAL (E.I.G.A.)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04-12
• Last Update Posted: 17 July 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients diagnosed of microscopic colitis (either lymphocitic or collagenous)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 192
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Age under 18
Pregnancy or lactancy
Either allergy or intolerance to the substance
Corticosteroids treatment contra-indications
Other causes of diarrhea

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified